|
||||||||||||||||
HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
I International Simposium on Hereditary Ataxias and II Caribbean Meeting on Dementias | ||||||||||||||||
August 18, 2002 | ||||||||||||||||
Center for Investigations and Rehabilitation on Hereditary Ataxias, Holguin Cuba 2002-11-15 Thursday, November 14, 2002 Participants Arrival to Holguin City. Registration and Pick up of Materials at Perkin Hotel, Room XXX from 2pm to 6pm Friday, November 15, 2002 7:30 to 12.00 am. Registration. 8:30- 8:40 am. Openning Remarks by Dr. Luis Velazquez Pérez 8:40-9:00 am Ataxia and Dementia in the Caribbean, Dr. Gladys Maestre Neurepidemiology 9.00 - 9.20 am. Cuban SCA2: The highest prevalence in the World. Dr. Luis Velázquez Pérez, MD, PhD. Center for the Investigation and Rehabilitation of Hereditary Ataxias, Holguín, Cuba. 9.20 - 9.40 am. Alzheimer´s Disease family in Medellín. Dr. Francisco Lopera. University of Antioquia, Medellín, Colombia 9.40 - 10.00 am. Current status of the Venezuelan Huntington´s Project (To be named) 10.00 - 10.30 am Discusión 10:30- 11:00 am. Coffe Break Neurogenetic in SCA2. 11.00 to 11:20 pm. SCA2 Animal models, normal function, and modifiers. Dr. Stephan M. Pulst, MD, PhD. Dept. of Neuro-genetics, Cedars Sinai Medical Center, UCLA, USA. 11:20 to 11:40 pm. Predictive Diagnosis in SCA2 (Lic. Milena Paneque Herrera) 11:40 to 12:00 m. Molecular Diagnosis in Cuban SCA2. Lic. Nieves Santos Falcón 12:00 to 12:20. Discussion. 12:20- 1:30 Posters 1.30 to 2.30 pm. Lunch. 2.30 to 2.50 pm Genetic Anticipation in Cuban SCA2. Lic. Luis Almaguer Mederos. 2.50 to 3.10 pm. Characterization of a transgenic rat model of Cuban SCA2. Julio R. Fernández, PhD. CIGB. 3.10 to 3.30 pm. Genotipical and Phenotipical Correlation in SCA2. 3.30 to 3.45 pm. Discussion 3:45 Adjurn for the day Saturday, November 16, 2002 Neurogenetics 8:30 to 8.50 am. A Complete Genome Scan For Familial Alzheimer's Disease Among Caribbean Hispanics From The Domican Republic and Puerto Rico (Dr. Richard Mayeux, USA) 8:50 - 9:10 am. ApoE in the Caribbean (Dra. Dalia Duarte, Cuba) 9:10 - 9:30 Presenilins (Dr. Francisco Lopera, Colombia ) 9:30 to 9:50 am. Discussion. 9:50 -10:20 Coffee Break 10.20 to 10:40 am Ethics of genetics studies in Neurodegenerative disorders (Dr. Victor Penchazadeh, US 10:40 to 11.00 am. Predictive Diagnosis in MJD (Dr. Jorge Sequeiros, MD, PhD). 11.00 to 11.20 pm. Genetic risk of late onset disease. Dr. Humberto Arboleda, Colombia. 11.20 to 11.40 pm. Discussion. 11:40-1:30 Posters 1:30 -2:30 Lunch. Experimental Approaches to Neurodegeneration disorders. 2.30 to 2.50 pm. Glutamate and neurodegeneration (Dr. Jose Ortiz, Puerto Rico).´ 2.50 to 3.10 pm. Biological activity of Huntingtin (Dr. Kimberly Kegel, Boston) 3.10 to 3.20 pm. Rol of Microglia in the patology of Alzheimer´s Disease (Dr. Amanda MacRae, Trinidad) 3.20 to 3.40 pm. Discussion 3.40 to 4.00 pm. Oxidative Stress, beta- Amiloid, presinilins and cell death (Dr. C. Vélez-Pardo, Colombia) 4.00 to 4.20 pm. NO and Oxidative Stress in SCA2. Dr. René Delgado Centro de Química Farmacéuticas, Ciudad Habana. 4.20 to 4:40.00 pm. GST in Cuban SCA2. Dr Julio César García Rodríguez. Centro de Producción de Animales de Laboratorio, Ciudad Habana. 4:40-5:10 pm. Discussion Sunday, November 17, 2002 Salón A. Dementia Culture, Education and dementia 8:30 -8:50 am. Low education level and dementia (D. Pineda, Colombia) 8:50- 9:10 am. Mild Cognitive impairment and illiteracy (G. Pino, Venezuela) 9:10- 9:30 am. Educational Program “With the look in the brain" Soc. Odalís Rojas, Venezuela. 9:30 to 9:50 am. Discussion 9:50-10:20 Coffee Break Treatment and care 10:20-10:40 Setting goals for the treatment of Alzheimer´s Disease (C. Gaona, Venezuela) 10:40-11:00. Accessibility and tolerance to pharmacological agents (R. Pardo, Colombia) 11:00-11:20 Managing sleep disturbances in the demented elderly (O. Sega, Venezuela) 11.20 to 11.40 am. Discussion 11:40-1:30 Posters 1:30 -2:30 Lunch. 12.05 to 1.15 pm. Lunch. 1.20 to 1.40 pm. Treatment Issues of dementia from a family perspective. (D. Eldemire, Jamaica) 1:40-2 pm. Informal care: The situation of Alzheimer's in Trinidad (J. Rawlins, Trinidad) 2:00- 2:20 Nutritional aspects of Dementia (MSc. Raquel Zambrano, Venezuela) 2:20-2:40 Alzheimer´s Association Resources available to the Caribbean (J Ward-Robinson USA) 2:40-3:00 pm Discussion 3:00-3:30 Coffee Break 3:30-4:30 Common lesson from Ataxia and Dementia 4:30 Closing Remarks Drs. Luis Velazquez Pérez and Gladys Maestre 2.50 to 3.05 pm. Discussion. 3.10 to 5.00 pm. To be named. 5.00 pm Conclussion in Room A Salón B. Hereditary Ataxias Phenotipo 9.00 to 9.15 am. Clinical Characterization of the Cuban SCA2. Dr. Edilberto Martínez Góngora. Center for the Investigation and Rehabilitation of Hereditary Ataxias 9.20 to 9.45 am. Saccadic eye movements in presymptomatic relatives and patients with SCA2. Dr. Luis Velázquez Pérez, MD, PhD. Center for the Investigation and Rehabilitation of Hereditary Ataxias 9.50 to 10.05 am. Disautonomic Disfunction in presymptomatic relatives and patients with SCA2. Dr Gilberto Sánchez Cruz. Center for the Investigation and Rehabilitation of Hereditary Ataxias 10.10 to 10.25 am. Discussion 10.30 to 10.45 am. Neurophysiological Studies in in Alzheimer´s Disease (Dra.María Antonieta Bobes, Cuba) 10. 50 to 11.05 am. Mental disorders in SCA2 Dr. Rubén Reynaldo Armiñán. 11.10 to 11.25 am. Discussion 11.30 to 12.00m. To be named 12.05 to 1.15 pm. Lunch. 1.20 to 2.00 pm. Room table Rehabilitation in SCA2. Lic. Ilbedys Pérez Avila. Lic. Julio C. Rodríguez Díaz. Lic. María Tereza Calero. Lic. Lisandra Prieto Avila. Lic. Alina Garcel Leyva. Center for the Investigation and Rehabilitation of Hereditary Ataxias. 2.05 to 2.20 pm. Discussion. 2.25 to 5.00 pm. To be named 5.00 pm Conclussion in Room A |
||||||||||||||||
Organized by: | Luis Velazquez Perez and Gladys E. Maestre | |||||||||||||||
Invited Speakers: | Neuroepidemiology Ataxia and Dementia in the Caribbean Dr. Gladys Maestre Venezuela Cuban SCA2: The highest prevalence in the World. Dr. Luis Velázquez Pérez, MD, PhD. Center for the Investigation and Rehabilitation of Hereditary Ataxias, (CIRAH) Holguín, Cuba. Alzheimer´s Disease family in Medellín. Dr. Francisco Lopera. University of Antioquia, Medellín, Colombia Neurogenetic in SCA2. SCA2 Animal models, normal function, and modifiers. Dr. Stephan M. Pulst, MD, PhD. Dept. of Neuro-genetics, Cedars Sinai Medical Center, UCLA, USA. Intranuclear Inclusions in SCA 2. Dra. Carola Seifried, MD. Goethe University. Frankfurt, Germany A Novel Autosomal Dominant Spinocerebellar Ataxia (SCA22) Linked to Chromosome 1q22-24. Bing-Wen Soong, MD, PhD. Department of Neurology, National Yang-Ming University School of Medicine and The Neurological Institute, Taipei-Veterans General Hospital, Taipei, Taiwan. Ethical Aspects of Predictive Prenatal Tests in Hereditary Ataxias. (Questões Éticas em Testes Preditivos Prénatais em Ataxias Hereditárias) Dr. José Roberto Goldim, MSc, PhD. Grupo de Pesquisa e Pós-Graduação Hospital de Clínicas de Porto Alegre. Predictive Diagnosis in SCA2 Lic. Milena Paneque Herrera, MsC. CIRAH, Cuba. Parkinson’s Disease Family. Neurogenetic Study Dr. Luis Heredero Bautes, MD, PhD. Centro Nacional de Genética Médica Cuba. Clinical, Diagnosis, Genetics and Molecular Basis of Wilson Disease (WD). Dr. Georgios Loudianos Italy Molecular Diagnosis in Cuban SCA2. Lic. Nieves Santos Falcón CIRAH, Cuba. Genetic Anticipation in Cuban SCA2. Lic. Luis Almaguer Mederos. CIRAH, Cuba. Characterization of a transgenic rat model of Cuban SCA2. Julio R. Fernández, PhD. CIGB, Cuba. A Complete Genome Scan For Familial Alzheimer's Disease Among Caribbean Hispanics From The Domican Republic and Puerto Rico Dr. Richard Mayeux USA ApoE in the Caribbean Dra. Dalia Duarte Hospital Finlay Cuba Presenilins Dr. Francisco Lopera, Colombia Ethics of genetics studies in Neurodegenerative disorders Ethical aspects of the investigations and practices of the presymptomatic diagnosis. Dr. Victor Penchazadeh, USA. Predictive Diagnosis in MJD Dr. Jorge Sequeiros, MD, PhD Portugal Genetic risk of late onset disease. Dr. Humberto Arboleda Colombia. Experimental Approaches to Neurodegeneration disorders. Glutamate and neurodegeneration Dr. José Ortiz Puerto Rico Biological activity of Huntingtin Dr. Kimberly Kegel Boston Rol of Microglia in the patology of Alzheimer´s Disease Dr. Amanda MacRae Trinidad Oxidative Stress, beta- Amiloid, presinilins and cell death Dr. C. Vélez-Pardo Colombia NO and Oxidative Stress in SCA2. Dr. René Delgado Centro de Química Farmacéuticas Cuba Glutation S-Transferasa in Cuban SCA2. Dr Julio César García Rodríguez. Centro de Producción de Animales de Laboratorio Cuba Culture, Education and dementia Low education level and dementia Dr. D. Pineda Colombia Mild Cognitive impairment and illiteracy Dr. G. Pino Venezuela Educational Program “With the look in the brain" Soc. Odalís Rojas Venezuela. Treatment and care Setting goals for the treatment of Alzheimer´s Disease C. Gaona Venezuela Accessibility and tolerance to pharmacological agents Dr. R. Pardo Colombia Managing sleep disturbances in the demented elderly Dr. O. Sega Venezuela Treatment Issues of dementia from a family perspective. Dr. D. Eldemir Jamaica Informal care: The situation of Alzheimer's in Trinidad Dr. J. Rawlins Trinidad Nutritional aspects of Dementia MSc. Raquel Zambrano Venezuela Alzheimer´s Association Resources available to the Caribbean J Ward-Robinson USA Phenotipo Clinical Characterization of the Cuban SCA2. Dr. Edilberto Martínez Góngora. CIRAH, Cuba Saccadic eye movements in presymptomatic relatives and patients with SCA2. Dr. Luis Velázquez Pérez, MD, PhD. CIRAH, Cuba Disautonomic Disfunction in presymptomatic relatives and patients with SCA2. Dr Gilberto Sánchez Cruz. CIRAH, Cuba Neurophysiological Studies in in Alzheimer´s Disease Dra.María Antonieta Bobes CNIC, Cuba Mental disorders in the Cuban SCA2 Dr. Rubén Reynaldo Armiñán. CIRAH, Cuba Room table Rehabilitation in SCA2. Lic. Ilbedys Pérez Avila. Lic. Julio C. Rodríguez Díaz. Lic. María Tereza Calero. Lic. Lisandra Prieto Avila. Lic. Alina Garcel Leyva. CIRAH, Cuba |
|||||||||||||||
Deadline for Abstracts: | 2002-10-10 | |||||||||||||||
Registration: | Participants: 180 USD Companions 60 USD Students 80 USD Caribbean Students 20 USD |
|||||||||||||||
E-mail: | neurocaribe@yahoo.com; ataxia@cristal.hlg.sld.cu | |||||||||||||||
Posted by: | Gladys E Maestre | |||||||||||||||
Host: | proxy.telcel.net.ve | |||||||||||||||
|
||||||||||||||||
Generated by meetings and positions 5.0 by Kai Garlipp |